---

$4.15

-2.1200 ( -33.80% ) 404.7K

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-29	Buy	3715.00	UBS Group AG
2024-02-23	Sale	-600.00	Basenese Lou
2024-02-23	Sale	-600.00	Harsh Michael
2024-02-23	Sale	-600.00	DIGIANDOMENICO ANTHONY
2024-02-23	Sale	-600.00	Tokman Alexander Y